MedTrace Logo MedTrace
Clinical Trials News Drugs Diseases Companies About

Ampligen

  1. Home
  2. Drugs
  3. Ampligen
  4. Clinical Trials

Clinical Trials Related to Ampligen

Related studies linked through entity extraction aliases.

NCT01312389

A Clinical Trial of Autologous Oxidized Tumor Cell Lysate Vaccine For Recurrent Ovarian, Fallopian Tube or Primary Peritoneal Cancer

Status
TERMINATED
Phase
PHASE1/PHASE2

NCT00215800

The Study of the Safety and Efficacy of Ampligen in Chronic Fatigue Syndrome

Status
COMPLETED
Phase
PHASE3

NCT00002269

A Multicenter, Double-Blind, Controlled Study to Evaluate Ampligen

Status
COMPLETED
Phase
NA

NCT00001000

A Study of Atvogen in Healthy Volunteers and HIV-Infected Patients Who Have No Symptoms of Infection

Status
COMPLETED
Phase
NA

NCT00000735

A Clinical Trial To Evaluate the Toxicity and Antiviral Effects of a Range of Doses of Ampligen in p24 Antigen Positive HIV-Infected Patients With AIDS or ARC

Status
COMPLETED
Phase
PHASE1

NCT00000713

A Phase I Clinical Trial To Evaluate the Toxicity, Antiviral and Immunomodulatory Effects of a Range of Doses of Ampligen in HIV-Infected Subjects

Status
COMPLETED
Phase
PHASE1

Clinical Trials

Explore studies by the year of their last update.

  • 2026
  • 2025
  • 2024
  • 2023
  • 2022
  • 2021
  • 2020
  • 2019
  • 2018
  • 2017
  • 2016
  • 2015
  • 2014
  • 2013
  • 2012
  • 2011
  • 2010
  • 2009
  • 2008
  • 2007
  • 2006
  • 2005

News & Analysis

Latest news and insights on clinical trials and medical research.

Browse All News →
MedTrace Logo MedTrace
About Privacy Policy Terms of Service Medical Disclaimer

© 2026 MedTrace.
Open-access medical & pharmaceutical data intelligence.